We analyzed the mechanism of action of the antiarrhythmic agent bertosamil on hKv1.5 channels expressed in Chinese hamster ovary cells (I hKv1.5 ) and on the outward current (I o ) of human atrial myocytes (HAMs) by using the whole cell patchclamp technique to record current. External application of 10 M bertosamil inhibited I hKv1.5 , accelerated its time-dependent decay, and slowed its deactivation. When bertosamil was applied at rest or intracellularly (50 M), it accelerated the rate of I hKv1.5 inactivation without change of the peak amplitude. At the steady-state effect of intracellular bertosamil, external drug application only inhibited I hKv1.5 . When cesium was the charge carrier, bertosamil inhibited I hKv1.5 but had no effect on its time course. Intracellular tetraethylammonium inhibited I hKv1.5 , suppressed its inactivation, and prevented bertosamil effects. Bertosamil-treated I hKv1.5 became highly sensitive to the rate of membrane stimulation and to cumulative inactivation phenomenon. In HAMs, bertosamil also increased the rate and extent of I o inactivation and slowed its recovery from inactivation, whereas after drug application I o became highly sensitive to cumulative inactivation phenomenon. In conclusion, bertosamil 1) causes a use-dependent inhibition of the current upon external drug application, and 2) accelerates the rate of current inactivation when applied at rest or intracellularly. These effects result from both an open-channel block and acceleration of the rate of channel inactivation and contribute to the modulation by bertosamil of I o in HAM.
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In human atrial myocytes the main repolarizing current that activates during the plateau-shaped action potential is a large voltage-dependent outward K ϩ current (I o ). This current is composed of an initial fast-inactivating component, followed by a large slowly inactivating component; the two components are usually designated I t and I sus , respectively (Escande et al., 1987) . The ratio between I t and I sus depends on age (Escande et al., 1985) and on clinical conditions such as atrial dilation (Le Grand et al., 1994) and chronic arrhythmia (Van Wagoner et al., 1997) and is controlled by intracellular regulatory factors (Tessier et al., 1999) . This current is sensitive to a number of pharmacological agents and is probably an important target of antiarrhythmic drugs used to treat atrial tachyarrhythmia (Wang et al., 1995) . The molecular basis of this current and the mechanisms involved in its regulation are thus a focus of attention.
A large part of this current is probably the functional expression of hKv1.5 channels, which are abundant in human atrial myocardium (Tamkun et al., 1991; Fedida et al., 1993; Wang et al., 1993) . These channels, when expressed in cell lines, carry a rapidly activating outward current that, in control conditions, inactivates slowly and has pharmacological characteristics similar to those of I sus (Snyders et al., 1993) . Indeed, cloned hKv1.5 channels are remarkably sensitive to a number of compounds, including antiarrhythmic agents (Snyders and Yeola, 1995; Delpon et al., 1999) . By binding to a hydrophobic site in the internal mouth of the pore of Kv channels, some of these compounds block the channels in the open position, with therapeutically valuable use-dependent inhibition of the repolarizing current (Snyders and Yeola, 1995; Yeola et al., 1996; Longobardo et al., 1998) . In addition, the frequency-dependent inhibition of the outward K ϩ current by drugs that block the channels in the open state can also arise from modulation of the intrinsic gating mechanisms, which govern the rate of channel inactivation (Baukrowitz and Yellen, 1996a; Rasmusson et al., 1998 ). This has been described with tetraethylammonium (TEA) compounds, which, by blocking the channel pore, reduce the outward K ϩ flow into the pore and, in turn, decrease the occupancy of K ϩ binding sites involved in the regulation of pore closure, thus leading to fast inactivation of shaker channels (Baukrowitz and Yellen, 1996b) .
Bertosamil is a structural analog of tedisamil, a new bradycardic class III antiarrhythmic agent with potential therapeutic efficacy in both atrial and ventricular tachyarrhythmia (Wallace et al., 1995; Fischbach et al., 1999; Singh, 1999) . We have previously reported that bertosamil accelerates the apparent rate of inactivation of the outward current in human atrial myocytes (Tessier et al., 1997) , acting in the same way as tedisamil on the outward current in rat ventricular myocytes (Dukes and Morad, 1989) . The effect of bertosamil on the outward K ϩ current of human atrial myocytes is also characterized by its irreversibility, enhanced current inactivation with membrane depolarization, a shift in its voltage-dependent activation, and an acceleration of the time to peak current, raising the possibility that the drug causes profound changes in the gating properties of channels carrying the outward current. Because bertosamil mainly affects I sus , the underlying mechanism may involve modulation of hKv1.5 channels.
This study was undertaken to investigate 1) the mechanism of action of bertosamil on cloned hKv1.5 channels expressed in the Chinese hamster ovary (CHO) cell line, and 2) whether the same mechanism affects endogenous channels in human atrial myocytes, and, if so, how it contributes to the modulation of the outward current by bertosamil.
Materials and Methods
Cell Preparation and Transfection. CHO cells were cultured in Ham's F-12 medium (nutrient mixture; Invitrogen, Cergy Pontoise, France), 10% fetal calf serum, 100 IU/ml penicillin, 100 g/ml streptomycin, and 0.25 g/ml amphotericin B (Invitrogen). hKv1.5 cDNA was generated by polymerase chain reaction from human heart RNA, checked by sequencing, and inserted into the pIRES2-EGFP expression vector (CLONTECH, Palo Alto, CA), the internal ribosome entry sequence generating a dual cistronic mRNA. Transfection was done using the FuGENE 6 kit (Roche Molecular Biochemicals, Mannheim, Germany), with 6 l of transfection reagent and 2 g of plasmid DNA per 35-mm dish; 36 h after the outset of transient transfection, cells were trypsinized and plated. Voltageclamp recording revealed typical hKv1.5 currents in 90 to 100% of cells expressing green fluorescent protein.
Atrial Myocyte Isolation. With approval from the ethics committee of our institution, myocytes were enzymatically isolated from samples of right atrial appendage obtained from 10 patients aged 44 to 78 years undergoing heart surgery for coronary insufficiency, mitral valve disease, or aortic valve disease. Most patients were on pharmacological treatments, which were stopped at least 10 h before surgery (Ca 2ϩ channel blockers, ␤-adrenergic antagonists, diuretics, angiotensin-converting enzyme inhibitors, or nitric oxide donors). The isolation procedure has been described in detail elsewhere (Tessier et al., 1999 
, NaCl in the external solution was replaced with an equimolar concentration of TEA or KCl. Patch pipettes were filled with an internal solution containing 115 mM K-aspartate, 5 mM KCl, 5 mM MgATP, 5 mM Na-pyruvate, 3 mM MgCl 2 , 5 mM EGTA, and 10 mM HEPES, adjusted to pH 7.2 with KOH. In experiments testing the effects of internal TEA, K-aspartate in the internal solution was replaced with an equimolar concentration of TEA. In some experiments, KCl was replaced by 140 mM cesium chloride (Cs ϩ ). Bertosamil [3-isobutyl-7-isopropyl-9,9-pentamethylene-3,7-diazabicyclo-(3.3 .1) nonane sesquihydrogenfumarate; KC 10784] was a gift from Dr. Ziegler (Solvay Pharma Deutschland, Hannover, Germany). Because bertosamil is a water-soluble drug, it was dissolved in the external or internal solution. 4-Aminopyridine was obtained from Sigma and was dissolved in the extracellular solution. All experiments were carried out at room temperature (22-24°C).
Data Analysis. I peak was measured as the difference between the amplitude of the peak current and the zero current; the amplitude of the maintained current I ss was measured as the difference between the current measured at the end of the 750-ms test pulse and the zero current; the amplitude of the initial fast-inactivating component of the outward current I t was calculated as the difference between I peak and I ss . The extent of I o or hKv1.5 current inactivation was quantified by measuring the fraction of outward K ϩ current inactivation, defined as the extent of inactivation ϭ (I total Ϫ I steady state )/ I total . The tail current decay was quantified as (tail current beginning Ϫ tail current end)/tail current beginning. The time course of I o or hKv1.5 current inactivation elicited by a 750-ms test pulse was best fitted by the sum of two exponential functions,
whereas the current elicited by a 5-s test pulse was best fitted by three exponential functions: 
where f is the percentage change in I hKv1.5 , IC 50 is the concentration producing half-maximal inhibition, n H is the Hill coefficient, and [D] is the concentration of bertosamil tested. Activation plots were generated by dividing I peak measured at a given potential by the difference between measured and reversal potential. Data on the conductance/voltage activation curve were best fitted with a Boltzmann distribution equation:
where G represents the conductance calculated at membrane potential V, V 1/2 the potential at which half the channels are activated, and k the slope factor. Recovery from inactivation was well fitted by a two-exponential function:
where A and B are amplitudes, t is time, and 1 and 2 are time constants. Statistical Analysis. Data are presented as means Ϯ S.E.M. Student's paired or unpaired t test was used to determine the significance of differences, as appropriate. P values of Ͻ0.05 were considered significant.
Results

Bertosamil Accelerates hKv1.5 Current Inactivation.
In CHO cells expressing hKv1.5 channels, 750-ms test pulses from Ϫ60 to ϩ50 mV delivered at 0.1 Hz elicited a rapidly activating outward current with a very slow rate of inactivation and a small extent of inactivation (0.09 Ϯ 0.03, n ϭ 12; Fig. 1A ). External application of 10 M bertosamil progressively inhibited the current (at ϩ50 mV, I ss : 862 Ϯ 248 versus 434 Ϯ 132 pA in control and bertosamil conditions, respectively, n ϭ 12, P Ͻ 0.01; Fig. 1A ), with a more marked effect on the current recorded at the end of the 750-ms test pulse (I ss ) than on the peak (I peak ). At steady state (reached after around 20 pulses at 0.1 Hz), this resulted in an increase in the extent of current inactivation compared with control conditions (0.41 Ϯ 0.05, n ϭ 12, P Ͻ 0.001) and a slow tail current (extent of decay: 0.67 Ϯ 0.05 versus 0.24 Ϯ 0.06, n ϭ 7, P Ͻ 0.001; Fig. 1B ). The effects of bertosamil on the currents were observed when the drug was applied at rest as illustrated in Fig. 1C , which shows the current traces recorded in control conditions and after bertosamil application during a 2-min rest period. The current recorded at the resumption of stimulation in the absence of drug (to avoid additional drug binding to the channel in its open state, trace 2) was characterized by a marked acceleration of time-dependent inactivation, resulting in steady-state suppression of I ss and a large transient component (I t ) (extent of inactivation: 0.11 Ϯ 0.04 versus 0.56 Ϯ 0.06, n ϭ 5, P Ͻ 0.05). Further application of bertosamil (traces 3 and 4) inhibited both I peak and I ss (I peak : Ϫ21.08 Ϯ 5.10%; extent of inactivation: 0.46 Ϯ 0.12, n ϭ 5, N.S.) without changing the current kinetics. Analysis of the concentration-dependent effects of external bertosamil on the I peak yielded IC 50 values of 39 M (n H of 1.0 Ϯ 0.2) and 11 M (n H of 0.9 Ϯ 0.2) for I ss (P Ͻ 0.05) (eq. 2 under Materials and Methods; Fig. 2, A and B) .
Effects of Intracellular Application of Bertosamil on hKv1.5 Current. To determine whether the rest-dependent effect of bertosamil arose from drug binding to an internal Fig. 1 . Effects of extracellular bertosamil on the hKv1.5 current in CHO cells. A and B, cell was pulsed at ϩ50 mV from a holding potential of Ϫ60 mV and then repolarized to Ϫ40 mV for 150 ms (at 0.1 Hz) to record the deactivation current (tail current). A, traces of current in the absence (E) and presence of 10 M external bertosamil (BT e , F); B, tail current in control (E) and bertosamil (F) conditions. Cell capacitance, 46 pF. C, current traces recorded in control conditions (1), after superfusion of the cell with external 10 M bertosamil during a 2-min rest period, at the resumption of stimulation (2), at the beginning (3) and steady-state (4) effects of 10 M bertosamil applied during a train of test pulses (0.1 Hz). Cell capacitance, 32 pF. site, cells were dialyzed with an internal solution containing 50 M bertosamil to obtain a complete drug effect. Figure 3A shows the superimposition of currents elicited by a test pulse from Ϫ60 to ϩ50 mV at 0.1 Hz, just after breaking the patch, and at various times of cell dialysis with a solution containing 50 M bertosamil. Internal bertosamil application caused gradual and marked inhibition of I ss , whereas I peak was not significantly modified; at steady state, this resulted in a current with a large extent of inactivation (0.60 Ϯ 0.03, n ϭ 12, P Ͻ 0.001) and a slow tail current (extent of tail current decay: 0.06 Ϯ 0.03, n ϭ 12, P Ͻ 0.001; Fig. 2B ). To compare the rate of inactivation of hKv1.5 current between control and internal bertosamil condition, membrane was depolarized during 5 s to allow the slow inactivation of the control current (eq. 1). This gave a 1 of 680.4 Ϯ 140.3 versus 29.4 Ϯ 4.1 ms (P Ͻ 0.001) and 2 of 3700.1 Ϯ 772.5 versus 295.1 Ϯ 38.3 ms (P Ͻ 0.001) in control (n ϭ 7) and bertosamil (n ϭ 8), respectively ( 3 was around to 4 s). After 5 min of internal bertosamil dialysis at rest (time required to obtained steadystate dialysis of the cell) the current recorded at the first pulse was already characterized by a large I t and a suppressed I ss , with no changes during subsequent pulses (Fig.  3C ). This suggested that the gradual decrease in I ss observed upon intracellular application of bertosamil during a train of pulses (Fig. 3A) resulted mainly from slow dialysis of the drug. External application of 10 M bertosamil in the presence of intracellular drug caused a additional inhibition of both I peak and I ss (I peak : Ϫ29.26 Ϯ 4.43%, n ϭ 4, n ϭ 5, P Ͻ 0.05; I ss : Ϫ24.70 Ϯ 4.10%, n ϭ 4, P Ͻ 0.05; Fig. 3D ). Figure 4 shows representative traces of currents elicited by 10-mV incremental 750-ms test pulses delivered at a frequency of 0.1 Hz from a holding potential of Ϫ60 mV in CHO cells dialyzed with control (Fig. 4A) or bertosamil-containing (Fig.  4B ) internal solution. The peak outward current-voltage relationship, normalized to control, was identical in the two conditions, whereas I ss was reduced in intracellular bertosamil conditions; the effect was significant at potentials above 0 mV (normalized currents at ϩ50 mV, 0.76 Ϯ 0.02 versus 0.32 Ϯ 0.04 in control and bertosamil conditions, Fig. 3 . A, effects of intracellular bertosamil (BT i ): superimposition of currents elicited by test pulses from Ϫ60 to ϩ50 mV and repolarized to Ϫ40 mV (at 0.1 Hz), just after breaking the patch (E) and at steady-state dialysis (5 min) (F) with a 50 M bertosamil-containing internal solution; B, tail currents in control (E) and bertosamil (F) conditions. Cell capacitance, 18 pF. C, trace of current elicited by the same protocol as in A after 5 min of intracellular dialysis with an internal solution containing 50 M bertosamil at rest. Cell capacitance, 21 pF. D, superimposition of current traces elicited by test pulses from Ϫ60 to ϩ50 mV and then to Ϫ40 mV (at 0.1 Hz) at the steady-state effect of internal application of 50 M bertosamil (E) and upon external application of 10 M bertosamil (F). Cell capacitance, 15 pF. respectively, n ϭ 11, P Ͻ 0.0001; Fig. 4, C and D) . The activation curve of the current was not modified by internal bertosamil (V 1/2 : 4.1 Ϯ 1.3 in C versus 2.5 Ϯ 1.2 in intracellular bertosamil (BT i ), n ϭ 8, N.S.; k: 23.0 Ϯ1.5 in C versus 26.4 Ϯ 1.8, n ϭ 8, N.S.) (eq. 4 under Materials and Methods; Fig. 4E ). These results suggested that bertosamil modulated I hKv1.5 by binding to distinct extra-and intracellular sites on the channel, the latter mediating the acceleration of the apparent rate of current inactivation. Ionic Sensitivity of Bertosamil Effect on Current. In these experiments we examined the mechanism responsible for the apparent acceleration of I hKv1.5 inactivation by bertosamil. First, we examined whether the nature of the monovalent cation flowing through the channels modulated the effect of bertosamil. Because the Cs ϩ current carried by hKv1.5 channels inactivates much less markedly than the K ϩ current (Fedida et al., 1999) , we tested the effect of replacing internal K ϩ by 140 mM Cs ϩ , which caused about a 5-fold reduction in current amplitude without changing the activation threshold (around Ϫ40 mV). As illustrated in Fig.  5A , the Cs ϩ current elicited by 750-ms pulses at ϩ50 mV was inhibited by 10 M external bertosamil applied during a train of pulses (Ϫ11.45 Ϯ 3.92%, n ϭ 5, P Ͻ 0.05), but its extent of inactivation was unaffected (0.04 Ϯ 0.01 versus 0.05 Ϯ 0.02, n ϭ 5, N.S.). The effects of bertosamil on the steady-state amplitude of the Cs ϩ current was significant at potentials above 0 mV (Fig. 5B) . As controls, and to check that the drug effectively bound to the channels, we used an external solution containing 80 mM potassium to shift the reversal potential for K ϩ (around ϩ15 mV versus Ϫ88 mV in control conditions), such that an inward potassium current could be recorded in the potential range of the voltage dependence activation of hKv1.5 channels (Fig. 5, C and D) . Figure  5C shows a superimposition of inward K ϩ currents recorded during a test pulse at Ϫ20 mV, before and after bertosamil application, in the same CHO cell as in Fig. 5A . In contrast to its effect on the outward Cs ϩ current, bertosamil not only suppressed the inward K ϩ current but also increased its extent inactivation (0.12 Ϯ 0.02 versus 0.34 Ϯ 0.01, n ϭ 4, P Ͻ 0.001; Fig. 5C ). Figure 5D shows the effects of bertosamil on the 80 mM K ϩ currents at various potentials (n ϭ 4). After bertosamil application in the presence of 80 mM external potassium and drug binding to the channels, the time-dependent inactivation of the Cs ϩ outward current (test pulse to ϩ50 mV), recorded again in the absence of external potassium, was still not altered.
Bertosamil Effects Are Suppressed by Internal TEA. External application of 30 mM TEA had a small but significant effect on the current recorded in the presence of intracellular bertosamil (I peak : Ϫ16.75 Ϯ 2.60%, P Ͻ 0.05; rate of inactivation: fast : 33.2 Ϯ 4.4 versus 44.4 Ϯ 5.0 ms, n ϭ 7, P Ͻ 0.01; extent of inactivation: 0.64 Ϯ 0.05 versus 0.56 Ϯ 0.06, n ϭ 7, P Ͻ 0.05; Fig. 6A ). An effect on the current obtained during bertosamil treatment was also observed when the [K ϩ ] o was increased (40 mM [K ϩ ] o versus 5 mM). High [K ϩ ] o reduced the amplitude and rate (I peak : Ϫ22.21 Ϯ 2.69%, P Ͻ 0.01; fast : 47.34 Ϯ 6.10 versus 68.98 Ϯ 8.30 ms, n ϭ 7, P Ͻ 0.01) and the extent of current inactivation (0.57 Ϯ 0.07 versus 0.49 Ϯ 0.07, n ϭ 7, P Ͻ 0.05; Fig. 6B ).
Intracellular application of TEA had a marked effect on the current and its modulation by bertosamil. Figure 7A shows that cell dialysis with an internal solution containing 30 mM TEA reduced the current amplitude (Ϫ41.70 Ϯ 6.20%, n ϭ 8, P Ͻ 0.01) and slowed the rate of tail current decay (extent of tail current decay: 0.69 Ϯ 0.01 versus 0.38 Ϯ 0.07, n ϭ 8, P Ͻ 0.01; Fig. 7B ). At steady-state dialysis with 30 mM TEA, external application of 10 M bertosamil during a train of pulses at 0.1 Hz had no significant effect on the rate of inactivation and slightly reduced the current amplitude (Ϫ7.94 Ϯ 3.50%, n ϭ 5, P Ͻ 0.05; Fig. 7C ). TEA suppression of the effects of bertosamil on current inactivation was already maximal at 3 mM TEA (Fig. 7D) . Moreover, in the presence of TEA, bertosamil failed to alter the time course of the current, even at a concentration of 100 M.
Effects of Rate and Duration of Membrane Depolarization on Current Treated with Bertosamil. After bertosamil application, the current became highly sensitive to the frequency of membrane depolarization, as indicated by experiments with a protocol involving delivery of a pair of depolarizing pulses from Ϫ60 to ϩ50 mV separated by an increasing time interval. In control conditions, the hKv1.5 jpet.aspetjournals.org Downloaded from current had almost entirely recovered after the shortest time interval tested (96.10 Ϯ 0.75% with a 4-ms interval, n ϭ 7, P Ͻ 0.05; Fig. 8A ), whereas the amplitude of the current elicited by the first pulse slightly decreased (85.10 Ϯ 0.20%, n ϭ 7, P Ͻ 0.05; Fig. 8A ). After intracellular application of bertosamil, I t was suppressed at the shortest coupling interval and slowly recovered with increasing interval duration: 80% of I t had recovered with an interval duration of 0.55 Ϯ 0.21 s versus Ͻ5 ms in C (n ϭ 7, P Ͻ 0.0001) and with rate constant 1 ϭ 142 ms and 2 ϭ 2687 ms, n ϭ 7 (eq. 5 under Materials and Methods; Figs. 8B and 10). To discriminate between channel recovery from drug binding or from inactivation as the main mechanism responsible for the effect of the rate of stimulation on I t , several protocols known to modulate channel inactivation were tested (Aldrich, 1981) . As shown in Fig. 9 , prolonged membrane depolarization with 5-s test pulses delivered at 0.1 Hz had a slight transient effect on control current, whereas in the presence of intracellular bertosamil it caused a marked suppression of I peak (Ϫ23.7 Ϯ 3.6%, n ϭ 8, P Ͻ 0.001) but not I ss (Ϫ3.9.1.7, n ϭ 8, N.S.; Fig. 9 ). Likewise, after intracellular bertosamil application, an increase in the rate of membrane depolarization from 0.1 to 1 Hz caused a marked and persistent decrease in the peak current, with little effect on I ss (n ϭ 5) (Fig. 9, C and  D) . When the cell was again paced at the low frequency of 0.1 Hz, I t showed slow partial recovery (Fig. 9) . In human atrial myocytes, too, bertosamil accelerates the rate of I o inactivation (Tessier et al., 1997) and slows its recovery from inactivation ( 1 ϭ 83 versus 1 ϭ 170 ms, n ϭ 7, P Ͻ 0.001; time necessary for 80% current recovery: 0.25 Ϯ 0.02 versus 1.32 Ϯ 0.30 s, n ϭ 7, P Ͻ 0.0001; Fig. 10 ); in addition, the current underwent a cumulative inactivation phenomenon at high rates of membrane depolarization as illustrated in Fig.  11 . Taken together, these results indicate that bertosamil increases the sensitivity of both the hKv1.5 current and I o in human atrial myocytes to the rate of stimulation and to cumulative inactivation phenomena.
Discussion
The main finding of this study is that berstosamil, a structural analog of the antiarrhythmic agent tedisamil, has two effects on the current carried by hKv1.5 channels: 1) a use- Fig. 6 . A, in CHO cells expressing hKv1.5 channels, superimposed currents evoked by 750-ms step depolarization from a holding potential of Ϫ60 to ϩ50 mV (at 0.1 Hz) before (E) and after exposure to 30 mM TEA (F), recorded at the steady-state effect of internal 50 M bertosamil. Cell capacitance, 33 pF. B, superimposed current tracings with 750-ms depolarizing pulses from a holding potential of Ϫ60 to ϩ50 mV (at 0.1 Hz) at the steady-state effect of internal 50 M bertosamil, recorded with 5 mM (E) and 40 mM (F) external K ϩ . Cell capacitance, 14 pF. The left-hand panels show raw data, and the right-hand panels show data after normalization to peak current values. Fig. 7 . Effects of internal TEA on the outward hKv1.5 current. A, CHO cell was pulsed, at 0.1 Hz, to ϩ50 mV from a holding potential of Ϫ60 mV and then repolarized to Ϫ40 mV for 150 ms to record the tail current; current traces were obtained just after breaking the patch (E) and at the steady-state effect of 30 mM internal TEA (F). B, tail currents elicited on return to Ϫ40 mV after 750-ms depolarizing pulses at ϩ50 mV, at the beginning (E) and steady state of internal TEA application (F). Cell capacitance, 15 pF. C, using the same depolarizing protocol as in A, superimposition of current traces obtained at the steady-state effect of 30 mM internal TEA (E) and upon 10 M bertosamil exposure (F). Cell capacitance, 18 pF. D, concentration-dependent effect of TEA on the bertosamil effect, expressed as changes in the extent of outward current inactivation. Results are expressed as means Ϯ S.E.M., and stars indicate statistical differences relative to control; n ϭ 8 at each concentration, except for 3 mM (n ϭ 4). jpet.aspetjournals.org dependent inhibition of the current observed during external drug application, and 2) an acceleration of time-dependent current inactivation when the drug is applied externally at rest, or internally, and that persists after drug washout. In human atrial myocytes, these effects of bertosamil on potassium channels may account for the changes in the time-and use-dependent properties of the outward potassium current. Mechanisms of Effects of Bertosamil on hKv1.5 Channels. The effects of bertosamil on the current carried by hKv1.5 channels may partly be explained by blockade of the channel pore in its open state. Such a mechanism could account for the time-dependent decrease in the current that occurred when bertosamil was applied during a train of depolarization, together with the increased magnitude of the drug effect with depolarization and the slowing of the deactivation tail current. However, various lines of evidence indicate that, in addition to this classic open-channel blockade, the acceleration of the time-dependent decrease in the current could also be due to drug modulation of the rate of channel inactivation. First, the acceleration of hKv1.5 current decay has also been observed in the absence of bertosamil in the extracellular medium (applied at rest, Fig. 1C ) and persisted for a long time after the drug was washed out.
Drug Modulation of hKv1.5 Channel and Human Myocytes
Second, the effects of bertosamil on hKv1.5 channels were modulated by interventions known to alter channel inactivation processes, such as the nature of the charge carrier, the extracellular concentration of K ϩ , TEA, and the rate and duration of membrane depolarization. Third, in the presence of intracellular bertosamil, or after external application of the drug during a rest period, only the use-dependent inhibitory effect was observed when the cell was again exposed to bertosamil, suggesting the existence of distinct sites of action of this agent. Finally, the effect of prolonged or rapid depolarization on the current does not support the possibility that the acceleration of Kv1.5 current decay by bertosamil is due Fig. 8 . Effects of bertosamil on the kinetics of current reactivation. Representative traces of the recovery from inactivation of the hKv1.5 current in control conditions (A) and at the steady-state effect of 50 M intracellular bertosamil (B) with a protocol consisting of two identical 750-ms pulses from Ϫ60 mV to ϩ50 mV, with interpulse intervals from 4 to 5000 ms. Cell capacitance, 16 and 21 pF, respectively. Fig. 9 . Effect of prolonged membrane depolarization on hkV1.5 current recorded in control condition (A) and after the steady-state internal application of 50 M bertosamil (B). Cell capacitance, 26 and 22 pF. Effect of increasing the rate of membrane depolarization from 0.1 to 1 Hz on hkV1.5 current recorded in control condition (C) and after the steadystate internal application of 50 M bertosamil in CHO (D). Cell capacitance, 27 and 25 pF, respectively. E, time course of inhibition of the peak current by high rate of depolarization and of its recovery at the resumption of the low rate of stimulation (0.1 Hz). mainly to drug release from the channel at a rate sufficiently rapid to allow the current to recover by the next pulse and to be blocked again. Both protocols caused a persistent inhibition of the transient but not the steady-state component of the bertosamil-treated current, despite the use of a pulse interval long enough to allow drug release from the channel.
Kv channels such as hKv1.5, which do not have an NH 2 -terminal part acting as an open-channel blocker, inactivate through a mechanism involving slow conformational changes at the outer mouth of the pore (Hoshi et al., 1991) . The slow inactivation of hKv1.5 mainly differs from classical C-type inactivation by its lower sensitivity to the external ion concentration, whereas permeating ions have a marked modulatory effect on this process (Fedida et al., 1999) . For instance, the Cs ϩ current carried by hKv1.5 channels inactivates much less than the K ϩ current. This could explain the low sensitivity of the Cs ϩ current to bertosamil. When K ϩ was the permeating ion, the channels in the same cell inactivated much faster and more extensively after drug application, pointing to a clear ion dependence of the bertosamil effect. We cannot rule out the possibility that competition in the channel pore between bertosamil and Cs ϩ binding, due, for example, to steric hindrance. But this is inconsistent with the observations that 1) Cs ϩ current is inhibited by bertosamil, indicating that the drug can bind to the channel in the presence of Cs ϩ ; and 2) after bertosamil application in the presence of high K ϩ the decay of the Cs ϩ current is still unaltered. The small magnitude of the effect of high external potassium concentrations on the current inactivated by bertosamil is also consistent with a modulation of hKv1.5 channel inactivation (Fedida et al., 1999) . Quaternary ammonium channel blockers such as TEA can bind to a site in the outer pore mouth and prevent slow C-type channel inactivation (Choi et al., 1991) . This is not the case of hKv1.5 channels, because their inactivation is poorly sensitive to external TEA, even after acceleration by bertosamil. TEA can also modulate slow C-type inactivation by binding, with relatively low affinity, to a site in the P-loop that is accessible on the intracellular part of the channel and prevents channel inactivation by an "allosteric" mechanism (Baukrowitz and Yellen, 1996b) . We found that intracellular application of TEA reduced the amplitude of the current and slowed its deactivation, suggesting that TEA blocks the channel and slows its transition from the open to the closed state. This is consistent with the inhibition by TEA and its derivatives of the deactivation gating of K ϩ shaker channels (Choi et al., 1993) . In the presence of intracellular TEA, bertosamil had a small inhibitory effect but failed to accelerate the rate of current inactivation, suggesting that TEA, by stabilizing the open-state channel, prevents bertosamil modulation of the conformational changes underlying channel inactivation (Choi et al., 1993) . The suppression by TEA of the effects of bertosamil on the current was not concentration-dependent and was not prevented by increasing the bertosamil concentration, making it unlikely that the two drugs compete for the same binding site.
The high current sensitivity to the frequency of stimulation after bertosamil application can also be explained by the acceleration of the rate of hKv1.5 channel inactivation by bertosamil. We found that increases in the rate or duration of membrane depolarization caused a gradual and persistent decrease in the current amplitude. This cumulative inactivation process (Aldrich, 1981; Marom and Levitan, 1994; Tessier et al., 2001) probably reflects the fact that recovery from inactivation is slow and that the number of channels available at the next pulse falls gradually as the time between pulses is reduced. Recently, it has been reported that the acceleration of the Kv1.5 current by nifedepine is mainly due to open-channel blockade independent of C-inactivation, because the drug rapidly binds and unbinds, which is not the case of the persistent bertosamil effects on K ϩ current (Lin et al., 2001) . This is not the first report of pharmacological modulation of the slow inactivation of Kv channels. For instance, tetraethylammonium compounds after blocking the channel pore, promote C-type inactivation by reducing outward K ϩ flow and, in turn, reducing occupancy of the K ϩ binding site involved in the regulation of pore closure, a process referred to as the permeation mechanism (Baukrowitz and Yellen, 1996b) . By analogy with the effects of quaternary ammonium blockers, and given that bertosamil acts on the cytoplasmic side of the channel, it is possible that the drug binds near the internal mouth of the pore, reduces K ϩ flow when the channels open, and thereby accelerates C-type inactivation. It is well established that the hKv1.5 channel has binding sites for various antiarrhythmic agents, which are located on the intracellular C-terminal part of the ␣-subunit. Through their hydrophobic interactions with sites located in the S6 segment, these compounds cause stereoselective open channel blockade, resulting in time-dependent current relaxation and a slowing of the tail current, which might also reflect a degree of acceleration of hKv1.5 channel inactivation when K ϩ flux is sufficiently reduced (Snyders and Yeola, 1995; Longobardo et al., 1998; Delpon et al., 1999) . Indeed, the similar effects of various compounds, including bertosamil, on hKv1.5 channels raise questions on the significance of these internal binding sites, which may be a structural requirement for normal channel function (England et al., 1995; Morales et al., 1996) .
Physiological Consequences. Our findings support previous reports that bertosamil and its analog tedisamil modulate the outward potassium current in rat ventricular (Dukes and Morad, 1989) and human atrial myocytes (Tessier et al., 1997) by accelerating its time-dependent inactivation. In this study we found that, in bertosamil-treated myocytes, I o recovers slowly from inactivation and undergoes jpet.aspetjournals.org marked cumulative inactivation when the rate of stimulation is increased, in a manner reminiscent of the behavior of the hKv1.5 current after drug application. The outward current in human atrial myocytes is the sum of distinct current components that may also be altered by bertosamil, thus preventing a direct extrapolation of the data obtained with cloned channels to the endogenous current. However, in a previous study we found that, in human atrial myocytes, bertosamil had little effect on the outward current that remained after application of 200 M 4-aminopyridine, suggesting a prominent effect of the drug on hKv1.5 channels (Tessier et al., 1997) .
Irrespective of the exact nature of the endogenous channels modulated by bertosamil, our observation that an antiarrhythmic agent regulates the mechanisms that control outward potassium current inactivation might have important implications. For instance, in keeping with the contribution of hKv1.5 channels to the repolarization of human atrial myocytes (Courtemanche et al., 1998) , bertosamil might have significant effects on the frequency-dependent adaptation of action potential, which is largely controlled by the inactivation, and the rate of recovery from inactivation, of the outward K ϩ current (Escande et al., 1985) .
